Epstein-Barr Protein Contributes To Cancer
Editor's ChoiceMain Category: Cancer / Oncology
Also Included In: Biology / Biochemistry; Genetics; Infectious Diseases / Bacteria / Viruses
Article Date: 03 Oct 2008 - 0:00 PDT
A protein in the Epstein-Barr virus (EBV) interferes with cellular processes that would normally prevent the preservation of damaged DNA, thereby promoting cancer development, according to an article released on October 2, 2008 in the open-access journal PLoS Pathogens.
EBV is a common herpesvirus in humans. Latent infection with this virus has previously been associated with several types of cancer. One such cancer is nasopharyngeal carcinoma (NPC), which affects the upper part of the throat. In NPC, very few proteins from EBV are actively expressed, one of which is EBNA1. This product is required to maintain EVB genomes, but it has never yet been clear how this protein might contribute to cancer.
In this study, a team at the University of Toronto showed that the EBNA1 protein disrupts certain structures in the nucleus of NPC cells, called PML nuclear bodies. These complexes contain the tumor suppressor promyelocytic leukemia protein, which generally regulate DNA repair and programmed cell death. By adjusting levels of EBNA1 in each cell type, EBNA1 induced PML protein and PML body loss in NPC cells.
According to the researchers, there is "an important role for EBNA1 in the development of NPC, in which EBNA1-mediated disruption of PML nuclear bodies promotes the survival of cells with DNA damage." Other EBV associated tumors, including B-cell lymphomas and gastric carcinoma, express EBNA1, indicating that this gene might play similar roles in the development of each of these cancers. Further investigation is needed to ascertain the full role of EBNA1 in these other EBV-induced cancers.
Epstein-Barr Nuclear Antigen 1 Contributes to Nasopharyngeal Carcinoma through Disruption of PML Nuclear Bodies.
Sivachandran N, Sarkari F, Frappier L
PLoS Pathog 4(10): e1000170.
doi:10.1371/journal.ppat.1000170
Click Here For Full Length Article
Written by Anna Sophia McKenney
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/articles/123844.php>
APA
http://www.medicalnewstoday.com/articles/123844.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
There Is A Fundamental Bias In This Research.
posted by Sergio Stagnaro MD on 3 Oct 2008 at 1:26 amFirst of all, not all individuals involved by Epstein Barr Virus, at least in their personal history, suffer from cancer in their life-span.
Secondly, cancer occurs in different biological systems, while the underlined protein is present in all tissues.
Thirdly, not all individuals are involved by Oncological Terrain "and" Oncological Terrain-dependent Inherited Real Risk, conditio sine qua non of oncogenesis (1-10)
1) Stagnaro Sergio, Stagnaro-Neri Marina. Introduzione alla Semeiotica Biofisica. Il Terreno oncologico. Travel Factory SRL., Roma, 2004.
http://www.travelfactory.it/semeiotica_biofisica.htm
2) Stagnaro S., Stagnaro-Neri M., Le Costituzioni Semeiotico-Biofisiche.Strumento clinico fondamentale per la prevenzione primaria e la definizione della Single Patient Based Medicine. Ediz. Travel Factory, Roma, 2004. http://www.travelfactory.it/semeiotica_biofisica.htm
3) Stagnaro S., Il dolore nella pancreatite acuta edematosa interstiziale. Com. IV Congr. Naz. AISD. Chieti-Pescara. Atti,1,V,3, 1980.
4) Stagnaro S. Genes and Cancer: a clinical view-point. The Oncological Terrain. BioMed Central Informatics.2004. http://www.biomedcentral.com/1471-2105/5/21/comments#10454
5) Stagnaro-Neri M., Stagnaro S., Pancreatite Acuta Edematosa Interstiziale. Diagnosi percusso-ascoltatoria. Acta Med. Medit. 3, 14
6) Stagnaro Sergio. Bed-Side Prostate Cancer Detecting, even in early stages (“Real Risk” of Cancer): BMC Family Practice, 6:24 doi:10.1186/1471-2296-6-24 http://www.biomedcentral.com/1471-2296/6/24/comments#202466
7) Stagnaro S. Newborn-pathological Endoarteriolar Blocking Devices in Diabetic and Dislipidaemic Constitution and Diabetes Primary Prevention. The Lancet. March 06 2007. http://www.thelancet.com/journals/lancet/article/PIIS0140673607603316/comments?totalcomments=18)
8)Stagnaro Sergio. Clinical tool reliable in bedside early recognizing pancreas tumour, both benign and malignant. World Journal of Surgical Oncology 2005, 3:62 doi:10.1186/1477-7819-3-62
9) Stagnaro S. New bedside way in reducing mortality in diabetic men and women. Ann. Int. Med. http://www.annals.org/cgi/eletters/0000605-200708070-00167v1
10) Sergio Stagnaro Mitochondrial Bed-Side Evaluation: a new Way in the War against Cancer (21 December 2005). Cancer Cell
Internationalhttp://http://www.cancerci.com/content/5/1/34/comments#218502
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





